Related Experiment Video
Updated: Sep 25, 2025

Optimizing Isolation and Purification of Murine Glomerular Mesangial Cells
Published on: March 7, 2025
Successful Treatment of COVID-19-Related Immune- Complex Glomerulonephritis, Case Report
Ramazan Danis, Emrah Gunay1, Enver Yuksel
1University of Health Sciences, Gazi Yasargil Training and Research Hospital, Nephrology Department , Diyarbakir, Turkey. egnay01@gmail.com.
Insights
Coronavirus infection can cause immune-complex glomerulonephritis, leading to acute kidney injury. Early diagnosis and treatment with steroids are crucial for managing this post-COVID-19 complication.
Area of Science:
- Nephrology
- Infectious Diseases
- Immunology
Background:
- Coronavirus disease (COVID-19) has been associated with various renal complications.
- Acute kidney injury (AKI), proteinuria, and hematuria are potential manifestations of COVID-19.
Observation:
- A 59-year-old male developed rapidly progressive kidney failure with pulmonary hemorrhage two months post-COVID-19 infection.
- Kidney biopsy revealed immune-complex glomerulonephritis, consistent with post-infectious glomerulonephritis.
- The patient presented with AKI and nephrotic syndrome, requiring hemodialysis.
Findings:
- Treatment included cyclophosphamide, methylprednisolone, and plasmapheresis initially.
- Subsequent treatment focused on methylprednisolone, with cyclophosphamide and plasmapheresis discontinued.
- The patient's condition improved with continued steroid therapy and supportive care.
Implications:
- Immune-complex glomerulonephritis is a recognized complication following COVID-19 infection.
- Prompt diagnosis and management, including steroid therapy, are essential for favorable outcomes.
- This case highlights the importance of considering glomerulonephritis in patients with renal dysfunction after COVID-19.
Abstract:
Acute kidney injury (AKI) , proteinuria in the nephrotic or subnephrotic range and hematuria might be seen in patients with coronavirus disease 2019 (COVID-19) infection. In this case study we present a 59 years old manwho was diagnosed with immune-complex glomerulonephritis after development of rapidly progressive kidney failure accompanied by pulmonary hemorrhage, 2 months after COVID-19 infection. The patient was hospitalised with the diagnosis of acute kidney injury and nephrotic syndrome. Hemodialysis was performed due to uremic symptoms. Cyclophosphamide, methylprednisolone and plasmapheresis were started. Pathologic examination of kidney biopsy revealed features compatible with immune complex-related acute glomerulonephritis. Cyclophosphamide and plasmapheresis were discontinued , and treatment with 1 mg/kg/day methylprednisolone was continued. Immune-complex glomerulonephritis can be seen following COVID-19 infection. İt is important to diagnose this disease entity as soon as possible . Steroidtherapy and other supportive modalities might be sufficient in the treatment. DOI: 10.52547/ijkd.6527.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome III : Nursing Management
Acute Pyelonephritis I: Introduction
Kidney Transplant II: Surgical Procedure

